Patents by Inventor Shelby Wyatt

Shelby Wyatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
    Patent number: 8841320
    Abstract: Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: September 23, 2014
    Inventors: Darryl J. Bornhop, H. Charles Manning, Mingfeng Bai, Shelby Wyatt Sinha
  • AGENTS FOR THERAPY EFFICACY MONITORING AND DEEP TISSUE IMAGING
    Publication number: 20080031823
    Abstract: Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.
    Type: Application
    Filed: July 13, 2007
    Publication date: February 7, 2008
    Inventors: Darryl Bornhop, H. Manning, Mingfeng Bai, Shelby Wyatt
  • Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
    Publication number: 20060147379
    Abstract: Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.
    Type: Application
    Filed: June 10, 2005
    Publication date: July 6, 2006
    Inventors: Darryl Bornhop, H. Manning, Mingfeng Bai, Shelby Wyatt